When a meta-analysis on results from experimental studies is conducted, differences in the study design must be taken into consideration. A method for combining results across independent-groups and repeated measures designs is described, and the conditions under which such an analysis is appropriate are discussed. Combining results across designs requires that (a) all effect sizes be transformed into a common metric, (b) effect sizes from each design estimate the same treatment effect, and (c) meta-analysis procedures use design-specific estimates of sampling variance to reflect the precision of the effect size estimates.
Extracting effect sizes from primary research reports is often the most challenging step in conducting a meta-analysis. Reports of studies often fail to provide sufficient information for computing effect size estimates, or they include statistics (e.g., results of significance tests of probability values) other than those needed by the meta-analyst. In addition, a set of primary research studies will often use different experimental designs to address the same research question. Although not commonly recognized, effect sizes from different experimental designs often estimate different population parameters (Ray & Shadish, 1996) and cannot be directly compared or aggregated unless adjustments for the design are made (Glass, McGaw, & Smith, 1981; Morris & DeShon, 1997) .
The issue of combining effect sizes across different research designs is particularly important when the primary research literature consists of a mixture of independent-groups and repeated measures designs. For example, consider two researchers attempting to determine whether the same training program results in improved outcomes (e.g., smoking cessation, job performance, academic achievement). One researcher may choose to use an independent-groups design, in which one group receives the training and the other group serves as a control. The difference between the groups on the outcome measure is used as an estimate of the treatment effect. The other researcher may choose to use a single-group pretest-posttest design, in which each individual is measured before and after treatment has occurred, allowing each individual to be used as his or her own control. 1 In this design, the difference between the individuals' scores before and after the treatment is used as an estimate of the treatment effect.
Both researchers in the prior example are interested in addressing the same basic question-is the training program effective? However, the fact that the researchers chose different research designs to address this question results in a great deal of added complexity for the meta-analyst. When the research base consists entirely of independent-groups designs, the calculation of effect sizes is straightforward and has been described in virtually every treatment of metaanalysis (Hedges & Olkin, 1985; Hunter & Schmidt, 1990; Rosenthal, 1991) . Similarly, when the studies all use repeated measures designs, methods exist for conducting meta-analysis on the resulting effect sizes (Becker, 1988; Dunlap, Cortina, Vaslow, & Burke, 1996; Gibbons, Hedeker, & Davis, 1993) . However, in many research areas, such as training effectiveness (Burke & Day, 1986; Dilk & Bond, 1996; Guzzo, Jette, & Katzell, 1985) , organizational development (Neuman, Edwards, & Raju, 1989) , and psychotherapy (Lipsey & Wilson, 1993) , the pool of studies available for a meta-analysis will include both repeated measures and independent-groups designs. In these cases, the meta-analyst is faced with concerns about whether results from the two designs are comparable.
Although our discussion focuses on combining effect size estimates from independent-groups and repeated measures designs, it is important to note that this is a general problem in meta-analysis and is not specific to these two designs. Unless a set of studies consists of perfect replications, differences in design may result in studies that do not estimate the same population effect size. Essentially the same issues have been raised for meta-analysis with other types of designs, such as different factorial designs (Cortina & Nouri, 2000; Morris & DeShon, 1997) or studies with nonequivalent control groups (Shadish, Navarro, Matt, & Phillips, 2000) .
The combination of effect sizes from alternate designs raises several important questions. Is it possible to simply combine these effect sizes and perform an overall meta-analysis? Do these effect sizes provide equivalent estimates of the treatment effect? How does the mixture of designs affect the computational procedures of the meta-analysis?
When dealing with independent-groups and repeated measures designs, the current literature does not offer consistent guidance on these issues. Some researchers have recommended that studies using a single-group pretest-posttest design should be excluded from a meta-analysis (e.g., Lipsey & Wilson, 1993) . Others have combined effect sizes across designs, with little or no discussion of whether the two designs provide comparable estimates (e.g., Eagly, Makhijani, & Klonsky, 1992; Gibbons et al., 1993) . Our perspective is that effect size estimates can be combined across studies only when these studies provide estimates of the same population parameter. In some cases, studies that use different designs will estimate different parameters, and therefore effect sizes from these studies should not be combined. In other cases, it will be possible to obtain comparable effect size estimates despite differences in the research design. The goal of this article is to discuss the conditions under which effect sizes should and should not be combined, so that researchers can make informed decisions about the best way to treat alternate designs in a particular research domain.
Much of this article focuses on the question of whether effect sizes are comparable across the alternate designs. For effect size estimates to be meaningfully compared across studies, it is necessary that (a) all effect sizes estimate the same treatment effect and (b) all effect sizes be scaled in the same metric. These two issues are reflected in the two parameters that compose the standardized mean difference effect size. The numerator reflects the mean difference between treatment conditions, and the denominator reflects the standard deviation of the population. If the effect sizes from different studies estimate different population mean differences or different population standard deviations, they cannot be meaningfully combined. For instance, studies with different operationalizations of the independent variable may produce different treatment effects (Cortina & DeShon, 1998; Hunter & Schmidt, 1990) . Also, the magnitude of the treatment effect can be influenced by the experimental design. Alternate experimental designs control for different sources of bias, potentially leading to different estimates of treatment effects. As a result, in many metaanalyses the experimental design is examined as a moderator of the effect size.
Another factor that affects the comparability of effect sizes across studies is the scaling of the effect size. Although the use of the standardized mean difference adjusts for differences in the scaling of the dependent variable across studies, it does not guarantee that the effect sizes have comparable metrics. Differences in study design can lead to different definitions of the relevant populations and, therefore, different standard deviations. For example, Morris and DeShon (1997) showed that the within-cell standard deviation from a factorial analysis of variance (ANOVA) reflects a population where the other factors in the design are fixed. The standard deviation from a t test, on the other hand, does not control for these other factors and, therefore, may reflect a different population. Effect size estimates computed from these different standard deviations would not be in the same metric and could not be meaningfully combined.
Similarly, the error term from a repeated measures t test is a function of the standard deviation of change scores, whereas the error term from an independent-groups t test is a function of the standard deviation of raw scores. These two tests reflect different conceptualizations of the relevant population, and both conceptualizations have been adopted as the basis for a repeated measures effect size. Some have argued that effect size from a repeated measures study should be defined in terms of the standard deviation of raw scores (Becker, 1988; Dunlap et al., 1996; Hunter & Schmidt, 1990) . Others (Gibbons et al., 1993; Johnson & Eagly, 2000) have defined the repeated measures effect size using the standard deviation of change scores. Both definitions of the effect size are reasonable; however, they reflect different population parameters. As long as all effect sizes are defined consistently, the analyst may select the effect size metric that best reflects the research question under investigation.
The purpose of this presentation is to highlight that effect sizes can be combined across independentgroups and repeated measures designs. However, doing so requires that (a) all effect sizes be transformed into a common metric, (b) effect sizes from each design estimate the same treatment effect, and (c) metaanalysis procedures use design-specific estimates of sampling variance to reflect the precision of the effect size estimates. In the following sections, we review the effect sizes that have been defined for alternate designs and discuss the conditions under which they will provide comparable estimates. In addition, we provide a general method whereby the meta-analysis can be conducted in the metric most appropriate for the analyst's research question.
Alternate Definitions of the Effect Size
In many research domains, the pool of primary studies contains a mixture of independent-groups and repeated measures designs, which could lead to different definitions of the effect size. We consider three common designs that can be distinguished along two dimensions. First, some designs use repeated measurements of the outcome variable (e.g., before and after treatment), whereas other designs measure the outcome only at a single point in time (posttreatment). Second, some designs compare results across independent groups (e.g., treatment and control groups), whereas other designs examine only the treatment group. These factors define three designs, each of which has led researchers to develop distinct definitions of the effect size.
In the independent-groups posttest design, the outcome is measured at a single point in time and is compared across independent groups that receive different treatments (e.g., experimental and control groups). When independent groups are analyzed, the research question focuses on the difference between groups relative to the variability within groups. The relevant parameters reflect the posttest means of the two treatment populations and the common standard deviation of scores within each population ( post ). For simplicity, we refer to experimental and control treatments ( post, E and post, C ), but the method can be generalized to other contrasts as well. Hedges (1981 Hedges ( , 1982 has defined the independent-groups effect size as follows:
If we assume homogeneity of variance, the best estimate of post is the pooled within-group standard deviation of posttest scores (SD post, P ). Therefore, the sample estimator of the independent-groups effect size is as follows:
where M post, E and M post, C are the sample posttest means of the experimental and control groups, respectively.
In the single-group pretest-posttest design, all participants receive the same treatment, and scores on the outcome are compared before and after treatment is administered. The research questions in the repeated measures design focus on change within a person, relative to the variability of change scores. Hence, these data are analyzed in reference to the population of change scores. This is illustrated by the repeated measures t test, where the denominator is a function of the standard deviation of change scores rather than the standard deviation of raw scores. Gibbons et al. (1993) defined the repeated measures effect size (␦ RM ) in terms of the population mean change ( D, E ) and standard deviation of change scores ( D, E ) in the experimental group,
which is estimated by the sample statistic,
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Here, M D, E is the sample mean change, or the mean difference between pre-and posttest scores, in the experimental group (M pre, E and M post, E ), and SD D, E represents the sample standard deviation of change scores.
In the independent-groups pretest-posttest design, the outcome is measured before and after treatment, and different groups receive different treatments (e.g., experimental and control groups). Becker (1988) recommended first computing an effect size within each treatment condition and then subtracting the controlgroup from the experimental-group effect size. The effect size for each treatment condition is defined as the pretest-posttest change divided by the pretest standard deviation ( pre ). Because pretest standard deviations are measured before any treatment has occurred, they will not be influenced by the experimental manipulations and are therefore more likely to be consistent across studies (Becker, 1988) . If homogeneity of pretest variances is assumed, the effect size for the independent groups pretest-posttest design (␦ IGPP ) is
Combining Results Across Designs
For effect size estimates to be combined across studies, it is essential that they estimate the same population parameter. Any differences in the designs of those studies could result in effect sizes that estimate different parameters. The three effect sizes defined above illustrate the potential for inconsistencies across independent-groups and repeated measures designs. Because each effect size is defined in terms of a different mean contrast and a different standard deviation, it will be appropriate to combine them in a meta-analysis only when the relevant parameters are equivalent across designs. In some cases, it will be reasonable to assume that the parameters are equivalent or can be transformed into an equivalent form. In other cases, effect sizes from alternate designs will not be comparable and should not be combined in a meta-analysis.
It is appropriate to combine effect sizes across designs as long as three requirements can be satisfied.
First, all effect size estimates must be placed in the same metric before aggregation is possible. Effect sizes for repeated measures data typically use different standard deviations than the effect size for the independent-groups posttest design. The use of different standard deviations results in incompatible scales, unless all effect sizes are transformed into a common metric.
Second, the meta-analyst must determine whether the effect sizes from different designs provide equally good estimates of the treatment effect. Some designs provide better control for sources of bias and therefore more accurately estimate the treatment effect. Combining results across designs is not appropriate if the designs yield effect sizes that are differentially affected by biasing factors. Therefore, before combining effect sizes across different designs, the metaanalyst must determine that potential sources of bias do not impact the effect size estimates. This could be accomplished conceptually, based on knowledge of the research methodologies used, or empirically, through moderator analysis.
Third, different designs estimate the treatment effect with more or less precision. Differences in precision should be taken into account when aggregating effect sizes across studies. This can be accomplished by weighting studies by the estimated sampling variance of the effect size, which is partly a function of the study design. Each of these issues is discussed in detail in the following sections.
Comparability of Metrics
Making accurate inferences when combining effect sizes across studies in meta-analysis requires that the effect sizes all be in the same metric (Glass et al., 1981) . Unless the scale of the dependent variable is standardized, differences in the measures used across studies could create artificial differences in effect size. Meta-analysis procedures entail the use of standardized measures of effect size such as the correlation coefficient (Hunter & Schmidt, 1990; Rosenthal, 1991) or the standardized mean difference between groups (Glass et al., 1981; Hedges, 1982) to accomplish this requirement. However, the use of a standardized effect size does not guarantee comparable scaling. Effect sizes from alternate designs may use different standard deviations (e.g., the standard deviation of pretest vs. posttest scores or of raw scores vs. change scores). Effect sizes from alternate designs will be comparable only if these standard deviations are the same or can be transformed into a common parameter.
One reason for different scaling of the effect size stems from the use of pretest versus posttest standard deviations (Carlson & Schmidt, 1999) . As shown in Equations 2, 4, and 6, the independent-groups effect size uses only posttest standard deviations; the independent-groups pretest-posttest effect size uses only pretest standard deviations; and the repeated measures effect size uses the standard deviation of difference scores, which is influenced by both pre-and posttest standard deviations. Thus, these effect sizes will be comparable only when the variability of scores is constant across time periods. This is consistent with a compound symmetric error structure for repeated measures data (Winer, 1971) . To the extent that treatment or time affects individuals differentially (a subject by time interaction), scores will grow more or less variable over time (Cook & Campbell, 1979) . In these cases, effect sizes computed using different standard deviations will not be comparable.
Even when the variance of scores is homogeneous across time, steps must be taken to ensure that effect sizes estimated from alternate designs are in the same metric. Because they use different standard deviations, d IG and d RM are not in the same metric. Fortunately, it is possible to translate effect sizes from one metric to the other. Such transformations have been discussed in previous work on meta-analysis, but these methods allow only transformation into the rawscore metric (e.g., Dunlap et al., 1996; Glass et al., 1981) . We adopt a more flexible approach whereby the researcher may transform all effect sizes into the metric most appropriate to address the research question.
Choosing an effect size metric. Before transforming effect sizes into a common metric, the metaanalyst must decide what the metric will be. Different metrics resulting from alternate study designs each represent legitimate, but different, definitions of the population. The choice depends on how the metaanalyst wishes to frame the research question.
The repeated measures and independent-groups designs reflect different ways of framing the research question, which lead to different definitions of the population effect size. Specifically, in the independent-groups design, individuals are assigned to different treatment conditions. The focus is on group differences in the level of the outcome measure. In contrast, in a repeated measures design, the same individual is observed under multiple treatment conditions. The interest is in how the individual's performance changes as a result of successive trials (Keppel, 1982) .
One reason researchers choose an independentgroups or repeated measures design is based on the match of the design with the research question. If the research question concerns the effectiveness of alternate treatments (e.g., different dosages of a drug), the focus is on whether differences between treatment groups exist. Hence, the independent-groups design is appropriate. On the other hand, research on change within an individual (e.g., learning or practice effects) is better analyzed using a repeated measures design, because this design allows the same individual to be tracked across conditions, thereby facilitating the analysis of change.
In a similar fashion, the definition of the effect size should reflect the research question. If the focus of the meta-analysis is on group differences, the mean difference between conditions is compared with the variability of scores within each condition (i.e., the rawscore metric). On the other hand, if the research focus is on change, mean change due to treatment should be compared with the variability of change scores (i.e., the change-score metric). The focus of the question on the level of performance versus the change in performance leads to the use of different standard deviations and thus to different definitions of the effect size.
Even when the mean difference is equivalent across the two designs ( D, E ‫ס‬ post, E − post, C ), d IG and d RM can differ considerably, because the mean difference is related to populations with different standard deviations. The difference between post and D is a function of the correlation between pre-and posttest scores (). Assuming equal standard deviations in preand posttest populations,
Consequently, the two definitions of the effect size are also related as a function of the pretest-posttest correlation,
When is greater than .5, D will be smaller than , and as a result, the repeated measures effect size will be larger than the independent-groups effect size. In contrast, when is less than .5, D will be greater than , and the independent-groups effect size will be larger. The two effect sizes will produce the same COMBINING RESULTS ACROSS DESIGNS IN META-ANALYSIS result only when ‫ס‬ .5, but even in this case they may have different interpretations. Research on the stability of performance over time suggests that the pretest-posttest correlation will often exceed .5, both for simple perceptual tasks (Fleishman & Hempel, 1955) and in more complex domains, such as job performance (Rambo, Chomiak, & Price, 1983) . Thus, use of the change-score metric will often produce larger effect sizes than the raw-score metric. The different interpretations of the two effect size metrics can be illustrated through an example. Kelsey (1961) conducted a study to investigate the effect of mental practice on task performance using a repeated measures design. For the purpose of this illustration, we assume that the same mean difference would have been obtained if the practice and no-practice conditions were independent groups (the appropriateness of this assumption is discussed in the following section). The independent-groups effect size would reflect the mean difference between practice and no-practice conditions, relative to the pooled within-group standard deviation:
This effect size estimates the average improvement relative to the variability in task performance in the population. Specifically, after mental practice, the average performance was 0.58 standard deviations above the average performance without practice. An alternative interpretation of the effect size is based on the overlap between distributions. Assuming that the populations are normally distributed with equal variance, one could conclude that the average performance after mental practice was greater than the performance of 72% of the no-practice population (see Figure 1 ). The results could also be represented as a repeated measures effect size, where the mean difference is divided by the standard deviation of change scores:
Here, the effect size indicates that the average improvement was 0.84 standard deviations above zero. The interpretation of d RM can be represented graphically by plotting the pre-and posttest scores for each individual (see Figure 2 ). For ease of interpretation, all of the individuals whose scores are depicted in the figure have the same mean score (pre-and posttest combined). Because mean differences between subjects do not influence the change scores, equating subjects on the mean score does not alter the result and provides a clearer picture of the variance in change scores. If we assume that the slopes of the lines have a normal distribution, a d RM of 0.84 implies that the change would be positive for 80% of the cases. That is, mental practice would be expected to produce an improvement in task performance for 80% of the population. The example reflects the common situation where the change-score metric produced a larger effect size estimate than the raw-score metric (because is greater than .5). This difference does not indicate over-or underestimation by one of the methods but rather reflects a difference in the focus of the research question.
The choice of a metric for the effect size should be guided by the analyst's research question. If the research focuses on differences across alternate treatments, the raw-score metric is preferred. On the other hand, if the focus of the research is on individual change, the change-score metric is most appropriate. In many situations, the same research question could be framed in terms of either metric. For example, the effectiveness of a training program could be expressed as the difference between training and no-training groups, suggesting the raw-score metric. Alternately, effectiveness could be defined as the amount of change produced as a result of training, suggesting the change-score metric. In either case, the effect size would reflect the difference between performance with and without training but would represent this difference in terms of different standard deviations. The choice will depend on whether the metaanalyst conceives of the relevant population as reflecting the level of versus the change in the outcome variable.
When choosing a metric for the effect size, researchers should also consider whether studies are sampled from populations with different values for , the correlation between pre-and posttest scores. If differs across studies, the variance of change scores will be heterogeneous, and d RM from these studies will be standardized in different metrics. If study characteristics that moderate can be identified (e.g., length of time between repeated measurements), subsets of studies with homogeneous could be analyzed separately. Alternately, effect sizes could be defined in the raw-score metric, which does not depend on the value of . Because the raw-score metric is not sensitive to variations in , it is recommended for situations in which the homogeneity of cannot be assumed and cannot be tested empirically.
When the research question does not clearly suggest use of one metric over the other, several additional factors should influence the choice. For example, it will generally be best to define the effect sizes in terms of the predominant design used in the pool of studies to be meta-analyzed. Studies that use a particular design are more likely to report the data needed to compute the effect size for that design. Therefore, matching the effect size metric to the design of the majority of studies will greatly facilitate the computation of effect sizes.
Another consideration is the ease of communicating results. A major advantage of the raw-score metric is its familiarity. The independent-groups effect size has been used in numerous meta-analyses, and most readers are familiar with its interpretation. Because the change-score metric represents a departure from this common approach, we recommend its use only in those situations in which the research question clearly calls for the analysis of change.
Transformations to produce a common metric.
When the population correlation between pre-and posttest scores is known, any of the effect sizes can be transformed into either the raw-score or change-score metric. It should be noted that these transformations only correct for differences in the metric (i.e., the standard deviation) of the effect size. They will not overcome disparities in how different designs estimate the mean difference between groups (i.e., differences in control for biasing factors).
To transform a repeated measures effect size into the raw-score metric, use
To transform an independent-groups effect size into the change-score metric, use
The transformed effect size in Equation 11 is similar to the effect size proposed for repeated measures data by Becker (1988 , cf. Morris, 2000 :
Although the two approaches will not produce exactly the same value, they are equivalent estimates of the population effect size. As long as pre-and posttest scores have equal population variances, the two estimates will have identical expectation and sampling variance. However, if variances are not equal over time, the use of the pretest standard deviation in Equation 13 would be preferable, because this value is unaffected by the treatment and therefore should be more consistent across studies (Becker, 1988) . Others have suggested pooling pre-and posttest standard deviations rather than using the pretest standard deviation in Equation 13 (Dunlap et al., 1996; Taylor & White, 1992) . The increase in the degrees of freedom should result in a better estimate of and thus a more precise estimate of ␦ IG . Unfortunately, the distributional properties of this estimator are unknown. Because the pooled standard deviation is computed from nonindependent samples, the degrees of freedom are less than if all observations were independent. However, the exact reduction in degrees of freedom is not known, and therefore a precise estimate of the sampling variance cannot be computed. Given the need to estimate the sampling variance, it is preferable to estimate the effect size using either Equation 11 or 13, for which the sampling variance is known.
Effect sizes from the independent-groups pretestposttest design could also be computed in either metric. If it can be assumed that the variance of scores is homogeneous across time, the effect size defined in Equation 6 (d IGPP ) will be in the same metric as d IG . Alternatively, the effect size could be computed in the repeated measures metric. This could be accomplished either by replacing the pretest standard deviation in Equation 6 with the standard deviation of change scores or by applying the transformation given in Equation 12.
Comparability of Treatment Effects
Often, meta-analysis includes studies involving a variety of experimental and quasi-experimental designs. Various designs have been developed to control for different sources of potential bias. To combine results across different designs, we therefore need to assume that the potential sources of bias do not impact effect size estimates. In the following sections, we outline the potential sources of bias for independentgroups and repeated measures designs and discuss the assumptions needed to combine effect sizes across these designs. We also describe methods to empirically evaluate the impact of biasing factors (e.g., moderator analysis), as well as methods that can be used to correct for bias.
The magnitude of the treatment effect (in the original metric) is represented by the difference between group means (i.e., the numerator of the effect size estimate). To illustrate the situations in which alternate designs provide comparable estimates of the treatment effect, we first describe a general model that articulates several key sources of bias. Then, we discuss how these biases influence the results in various research designs. This model is intended to illustrate the types of bias that can occur in independent-groups and repeated measures designs. A more comprehensive discussion of the strengths and weaknesses of alternate designs can be found in a text on quasiexperimental design (e.g., Cook & Campbell, 1979) . Furthermore, researchers conducting meta-analysis should consider the design issues most relevant to the particular research domain they are studying.
Consider a study in which participants are assigned to either a treatment or a control group, and a dependent variable is measured in both groups before and after the treatment is administered. The pretest score for the ith individual in group j is denoted by Pre ij .
Similarly, posttest scores are denoted by Post ij . The various factors influencing scores in each condition are illustrated in Figure 3 .
Pretest scores are influenced by the population grand mean (), a selection effect (␣ j ), and a random error term (⑀ ij1 ). The population grand mean refers to the pretest mean of the common population from which participants are sampled, before any selection, treatment, or other events occur. ⑀ ij1 and ⑀ ij2 refer to the random error terms affecting pretest and posttest scores for individual i in treatment group j. The model assumes that all errors are independent and that the expected error in each condition is zero. The selection effect is equal to the population difference between the group pretest mean and the grand mean. The selection effect reflects any factors that produce systematic group differences between experimental and control groups on the pretest. For example, suppose that men were assigned to the experimental condition, whereas women were assigned to the control condition: would refer to the grand mean across gender, ␣ E would be the difference between the mean pretest score for men and the grand mean, and ␣ C would be the difference between the pretest mean for women and the grand mean. Such effects are likely in nonequivalent control group designs (Cook & Campbell, 1979) , in which self-selection or other nonrandom factors can influence group membership. If partici- Figure 3 . Potential sources of bias in treatment effect estimates. Pre ‫ס‬ pretest score; Post ‫ס‬ posttest score; ‫ס‬ mean of pretest population; ␣ ‫ס‬ selection effect; ␥ ‫ס‬ time effect; ⌬ ‫ס‬ treatment effect; ␤ ‫ס‬ relationship between preand posttest scores; ⑀ ‫ס‬ random error term. Subscripts indicate individual participants (i), treatment versus control groups (E and C), and pre-versus posttest scores (1 and 2). pants are randomly assigned to experimental and control conditions, ␣ j would be zero.
Posttest scores will be influenced to some degree by the individual's standing on the pretest. The slope of the relationship between pre-and posttest scores is indicated by ␤ j . If pre-and posttest scores have equal variances, ␤ j is the within-group correlation between the pretest and posttest. The model assumes that this relationship is the same for all participants within a group but may differ across groups.
Posttest scores are also potentially influenced by a time effect (␥ j ) and a treatment effect (⌬ E ). ␥ j reflects any factors that might systematically alter scores between the pretest and posttest but are unrelated to the treatment. Examples of such effects are maturation, history, or fatigue (Cook & Campbell, 1979) . ⌬ E reflects the change in scores that is directly caused by the treatment. Because the control group does not receive the treatment, ⌬ C ‫ס‬ 0 by definition and is therefore excluded from Figure 3 . Both ⌬ E and ␥ j are assumed to equally affect all individuals within a treatment condition; however, the time effect is not necessarily the same for treatment and control groups.
Following the model, pretest scores can be written as
It is further assumed that, absent any time or treatment effect, the expected pre-and posttest means would be equal. Specifically, it is assumed that the expected value on the posttest, given a score at the mean of the pretest, would equal the expected value of the pretest, or
From this assumption, posttest scores in the presence of treatment and time effects can be written as
where ⌬ j ‫ס‬ 0 for the control group. We can use this model to examine how alternate designs would estimate the treatment effect. Independent-groups posttest design. In the independent-groups posttest design, the treatment effect is computed from the difference between the two posttest means. The expected value of the difference between means is as follows:
If one were to further assume that time affected both groups equally, and that there was no selection bias, the expected value would equal the true treatment effect.
Single-group pretest-posttest design. If a single group is measured before and after treatment, the treatment effect is estimated from the mean of the change scores. The difference between Post E and Pre E is as follows:
The expected value of the average change score is
Thus, the standard pretest-posttest design accurately estimates the treatment effect only when the time effect is zero. Independent-groups pretest-posttest design. If pre-and posttest scores are available for both the treatment and control groups, a common method of analysis would be to test for the difference across groups in the mean pretest-posttest change. The change score for the experimental group is given in Equation 18 . The change score for the control group is (20) and the expected value of the difference between average change scores is
Therefore, this design accurately estimates the treatment effect when the time effect is equivalent across groups. When the assumption of equal time effects cannot be met, data from this design can still be used to estimate the same treatment effect (subject to the same bias) as either of the other two designs, simply by using the appropriate means. That is, the treatment effect could be estimated from the difference between posttest means (comparable to the independentgroups posttest design) or from the mean posttestpretest difference in the experimental group (comparable to the single-group pretest-posttest design). However, both of these estimates ignore part of the available data and therefore will provide less precise and potentially more biased estimates when the assumption is met.
Data from this design can also be analyzed using analysis of covariance (ANCOVA), with pretest scores as the covariate. A related approach is to com-pute the mean difference between covariance-adjusted means or residualized gain scores, which are defined as the residual term after regressing the posttest scores onto pretest scores. Both approaches provide the same estimate of the treatment effect (Glass et al., 1981) . These approaches are particularly useful when the pretest and posttest scores are in different metrics (e.g., because of the use of different measures), in which case the gain score would be difficult to interpret. Unfortunately, because the comparison is based on adjusted means, the treatment effect estimated with these methods will be comparable to the other designs only under restrictive conditions. According to Maris (1998) , ANCOVA will provide an unbiased estimate of the treatment effect only when selection into groups is based on the individual's standing on the covariate. Except in unusual cases (e.g., the regression-discontinuity design; Cook & Campbell, 1979) , this condition is unlikely to be met, and therefore the difference between adjusted means will not be comparable to treatment effects from other designs.
When are estimates equivalent? As can be seen by comparing Equations 17, 19, and 21, each estimate of the treatment effect is subject to different sources of bias. Table 1 provides a summary of the designs, the effect size metrics, and the potential sources of bias that may influence the effect size estimates. In the absence of bias, all effect sizes provide equivalent estimates of the treatment effect. However, the effect size estimates will often differ when the sources of bias have a nontrivial effect on the results. Therefore, it is not appropriate to aggregate effect sizes across the different designs unless the potential sources of bias can be ruled out through either rational or empirical methods.
The independent-groups posttest design does not control for selection effects and therefore will often be incompatible with results from the other designs. Lack of random assignment to treatment conditions can bias the estimate from the independent-groups posttest design but has no effect on the other designs. When it can be assumed that assignment to groups is random, the expected value of the selection effect should be zero.
In the single-group, pretest-posttest design it is assumed that all change over time is due to the treatment. In contrast, the other designs require the assumption that change over time is equivalent across conditions. Only when there is no time effect will all three designs be unbiased. 
Note. post ‫ס‬ posttest; E ‫ס‬ experimental group; C ‫ס‬ control group; P ‫ס‬ pooled (i.e., the standard deviation was pooled across experimental and control groups); pre ‫ס‬ pretest; D ‫ס‬ pre-post difference scores. a We assume that the pretest standard deviation provides an unbiased estimate of . b The sources of bias will be the same regardless of the effect size metric.
In many areas of research, it is unrealistic to assume that there will be no time effect in the control group. For example, if change over long periods of time is looked at in a study, it is very likely that maturation or history effects would occur, suggesting that the time effect will be nonzero. Research on psychotherapy (Lipsey & Wilson, 1993) and training (Carlson & Schmidt, 1999) frequently demonstrates nonzero change in the control group.
However, in other domains, there may be no reason to expect a change absent treatment. In experimental research comparing performance of the same subject under different conditions, many researchers use counterbalancing of conditions, so that the mean difference between treatments will not be influenced by the order of presentation. A time effect would have the same impact on treatment and control group means and therefore would not bias the estimate of the treatment effect. Other research applies repeated measures over relatively short periods of time under controlled laboratory conditions. In such cases, maturation or history should have little effect. For example, in a meta-analysis on the effects of self-reference on memory (Symons & Johnson, 1997) , studies using a single-group pretest-posttest design produced a mean effect size that was very close to the estimate from studies that included a control group.
Furthermore, the assumption of no change in the control group may be viable for variables that are resistant to spontaneous change. For example, in a meta-analysis on psychological treatments for insomnia, Murtagh and Greenwood (1995) combined studies using both the independent-groups posttest design and the single-group pretest-posttest design. The authors argued that it was appropriate to aggregate effect sizes across these two designs, because spontaneous recovery from chronic insomnia is unlikely to occur. This decision was supported by their results, which showed a similar mean effect size across designs. Similarly, in a meta-analysis of training studies, Carlson and Schmidt (1999) found changes in the control group for some variables, but no substantial change was found for measures of trainee attitudes.
Even when time effects occur, effect sizes can be combined across designs under certain conditions. When there is an equivalent time effect across groups, both designs involving independent groups will be unbiased and therefore can be combined. This would be reasonable if the time effect was due to maturation and group assignment was unrelated to maturation rates.
Other types of time effects, such as fatigue, may be related to the treatment, and therefore it may not be appropriate to assume equivalence across groups. In such cases, it may be reasonable to assume no time effect in the control group. With this assumption, effect sizes from the single group pretest-posttest and independent-groups pretest-posttest designs can be combined, although both will be biased estimates of the treatment effect.
In addition to the sources of bias discussed in this section (selection, time, and differential time effects), Table 1 also indicates susceptibility to bias produced by a subject by treatment interaction. This form of bias will not affect the estimation of the treatment effect, but it can bias the estimation of the standard deviation as discussed in the Comparability of Metrics section. Because the subject by treatment interaction will inflate or deflate posttest variance, any effect size that uses posttest standard deviations is susceptible to this form of bias. Effect sizes from the single-group pretest-posttest and the independent-groups pretestposttest designs will be unbiased if computed in the raw-score metric (using pretest standard deviations) but will be susceptible to bias when computed in the change-score metric. Results from the independentgroups posttest only design will be susceptible to this bias regardless of the metric of the effect size, because only posttest standard deviations would be available (Carlson & Schmidt, 1999 ).
An alternative way to justify aggregation of effect sizes across designs would be to determine empirically whether alternate designs provide similar estimates of the effect size. As a first step in a metaanalysis, a moderator test could be performed to compare effect sizes across designs. If the mean effect sizes differ substantially, then separate analyses should be performed for each design. However, if similar mean effect size estimates are found for the alternate designs, they could be combined into a single meta-analysis. Of course, it would also be possible that differences in the bias in the various estimators would be confounded by differences in other study characteristics. As a means of getting around this problem, the study design could be used as one of several moderators analyzed simultaneously in the meta-analysis (Hedges & Olkin, 1985) .
Correcting for sources of bias. Often, it will not be possible to assume that potential biasing factors have no effect. In some cases, it may still be possible to integrate effect sizes across designs if the relevant sources of bias can be estimated from the available data. One of the advantages of aggregating results across studies is that the strengths of one study can compensate for the weaknesses of another. If some studies provide adequate data to estimate a potential source of bias, this estimate can be applied to other studies in order to obtain unbiased estimates of the effect size in all studies.
Consider a meta-analysis in which some of the studies use a single-group pretest-posttest design and others have an independent-groups pretest-posttest design. Whenever there is a nonzero pretest-posttest change in the control group (␥ C ), effect sizes from the two designs will estimate different parameters. If it can be assumed that the time effect (␥) is the same for the treatment and control groups, the independentgroups pretest-posttest design will provide an unbiased estimate of the population effect size, whereas the single-group pretest-posttest design will overestimate the effect of treatment. However, when sufficient information is available, it is possible to obtain an unbiased estimate using effect sizes from both designs. Becker (1988) described two methods that can be used to integrate results from single-group pretestposttest designs with those from independent-groups pretest-posttest designs. In both cases, meta-analytic procedures are used to estimate the bias due to a time effect. The methods differ in whether the correction for the bias is performed on the aggregate results or separately for each individual effect size. The two methods are briefly outlined below, but interested readers should refer to Becker (1988) for a more thorough treatment of the issues.
The first approach would be to aggregate the pretest-posttest effect sizes separately for the treatment and control groups. For each independent-groups pretest-posttest study, one effect size would be computed based on the pre-and posttest means of the treatment group, and a separate effect size would be computed based on the pre-and posttest means for the control group. The single-group pretest-posttest design would only provide an effect size for the treatment group. In order to account for the fact that multiple effect sizes are included from the same study, a mixed model analysis could be used to estimate the mean standardized pretest-posttest change for the treatment and control groups. The result for the control group provides an estimate of the time effect, and the difference between the two estimates provides an unbiased estimate of the population effect size. A similar method has been suggested by Li and Begg (1994) .
A disadvantage of this method is that separate effect size estimates are required for treatment and control groups. Therefore, it would not be possible to integrate these results with effect sizes from studies using an independent-groups posttest design. Using Becker's (1988) second method, it may be possible to combine results from all three designs.
Rather than correcting for bias at the aggregate level, it is also possible to introduce a bias correction for individual studies. A preliminary meta-analysis would be conducted on control groups from the studies with independent-groups pretest-posttest designs. The mean standardized pretest-posttest change from these studies provides an estimate of the time effect (␥ C ). If this time effect is assumed to be the same in the treatment condition, then the mean time effect can be subtracted from each of the effect size estimates for the single-group pretest-posttest designs. As a result, both designs will provide an unbiased estimate of the treatment effect. Furthermore, under conditions in which the independent-groups posttest design provides an unbiased estimate of the treatment effect, effect sizes from all three designs will be comparable and could therefore be combined in the same meta-analysis.
Because this method uses the results from one set of studies to estimate the correction factor for other studies, the effect size estimates will not be independent. Therefore, standard meta-analysis models, which assume independence, will not be appropriate. Consequently, Becker (1988) recommended the use of a generalized weighted least squares model for aggregating the results.
An important assumption of this method is that the source of bias (i.e., the time effect) is constant across studies. This assumption should be tested as part of the initial meta-analysis used to estimate the pretestposttest change in the control group. If effect sizes are heterogeneous, the investigator should explore potential moderators, and if found, separate time effects could be estimated for subsets of studies.
Similar methods could be used to estimate and control for other sources of bias. For example, Shadish et al. (2000) conducted a separate meta-analysis on the difference between pretest scores for treatment and control groups. This pretest effect size provided an estimate of the degree of bias resulting from nonrandom assignment.
Sampling Variance Estimates
Sampling variance refers to the extent to which a statistic is expected to vary from study to study, sim-ply as a function of sampling error. Estimates of sampling error are used in a meta-analysis when computing the mean and testing the homogeneity of effect sizes. Sampling variance is largely a function of the sample size but is also influenced by the study design. For example, when is large, the repeated measures design will provide more precise estimates of population parameters, and the resulting effect size will have a smaller sampling variance.
Variance formulas have been developed for both the independent-groups (Hedges, 1981) and repeated measures effect size (Gibbons et al., 1993) . In addition, Becker (1988 , cf. Morris, 2000 and Hunter and Schmidt (1990) have developed slightly different formulas for an effect size in the raw-score metric estimated from repeated measures data. Rather than relying on these separate formulas, we present a general form of the variance that encompasses the three existing procedures, as well as a new situation, that is, an effect size in the change-score metric estimated from an independent-groups posttest design.
The general form for the sampling variance (
) for an effect size in either metric is
The derivation of this formula is presented in Appendix A. Each of the variables in Equation 22 can take on different values, based on the design of the study and the metric of the effect size. ␦ * refers to the population effect size in the metric chosen for the metaanalysis. The bias function c(df ) is approximated by the following (Hedges, 1982) :
When the data are from an independent-groups posttest design, ñ‫ס‬ (n E * n C )/(n E + n C ), and df ‫ס‬ n E + n C − 2. If the data are from a single-group pretestposttest design, ñ is the number of paired observations, and df ‫ס‬ n − 1. In addition, if the result is expressed in a different metric than the original design, the appropriate transformation (as illustrated in Equations 11 and 12) is substituted for A. The resulting variance for each type of effect size is indicated in Table 2 .
The sampling variance formulas are somewhat more complex when the effect size is estimated from an independent groups pretest-posttest design. As shown in Equation 6, separate effect size estimates would be calculated for the treatment and control groups. The difference between these two components effect sizes provides the best estimate of the overall effect size for the study. The variance of this combined effect size is equal to the sum of the variances for the two components (Becker, 1988) . Thus, the variance would be estimated for each group, using the appropriate equation from Table 2 , and then summed.
Table 2 Sampling Variance of the Effect Size as a Function of the Study Design and the Metric Used in the Meta-Analysis

Study design
Effect size metric Sampling variance
Single-group pretest-posttest Change score
Single-group pretest-posttest Raw score
Independent-groups posttest Change score
Note. n is the number of paired observations in a single-group pretest-posttest design; ␦ RM and ␦ IG are the population effect sizes in the change-score and raw-score metrics, respectively; c(df ) is the bias function defined in Equation 23; ñ ‫ס‬ (n E * n C )/(n E + n C ); N is the combined number of observations in both groups (n E + n C ).
Operational Issues in Estimating Effect Sizes
Estimating the Pretest-Posttest Correlation
Transforming effect sizes into alternate metrics requires an estimate of the population correlation between pre-and posttest scores. Others have avoided this step by computing the independent-groups effect size from means and standard deviations (Becker, 1988; Dunlap et al., 1996; Hunter & Schmidt, 1990) . However, the pretest-posttest correlation is also used in the estimate of the sampling variance and therefore will have to be estimated regardless of which approach is used. In addition, it may be possible to estimate from studies in which sufficient data are available and to generalize this estimate to other studies. This is similar to common procedures for estimating study artifacts (e.g., reliability) based on incomplete information in primary research reports (Hunter & Schmidt, 1990) . Thus, the analyst would first perform a preliminary meta-analysis on the pretestposttest correlations and then use the result as the value of in the transformation formula. A variety of methods exist to aggregate correlation coefficients across studies, involving various corrections, weighting functions, and so forth (e.g., Hedges & Olkin, 1985; Hunter & Schmidt, 1990; Rosenthal, 1991) . We do not advocate any particular approach but rather rely on the meta-analyst to determine the most appropriate methods for the estimation of .
It is not necessary to assume that a single value of is appropriate for all studies. Some may feel that will change as a function of study characteristics, such as the length of time between pre-and posttest measures (Dunlap et al., 1996) . A test for homogeneity of effect size (Hedges & Olkin, 1985) can be used to evaluate whether the estimates of are consistent across studies. If this test is significant, the differences in could be modeled as part of the initial metaanalysis, and then appropriate values estimated for each study.
As noted earlier, the homogeneity of also has implications for the choice of an effect size metric. Effect sizes defined in the change-score metric should be combined only for studies where is the same. To use the change-score metric when varies across studies, the researcher should perform separate metaanalyses for subsets of studies that have homogeneous . Alternatively, the meta-analysis could be conducted in the raw-score metric, which is not affected by variations in .
Although the pretest-posttest correlation may not be included in all study reports, it is often possible to compute this value from available data. If both the pre-and posttest standard deviations (SD pre and SD post ) are known, as well as the standard deviation of difference scores (SD D ),
can be used to compute the pretest-posttest correlation. If the pre-and posttest standard deviations are not known, r can also be estimated from the pooled standard deviation (SD P ),
The derivations of Equations 24 and 25 are presented in Appendix B.
If the variance of difference scores is not reported, it can often be computed from test statistics and then substituted into one of the above equations. For example, if the means, sample size, and repeated measures t test (t RM ) are reported,
Estimating Effect Sizes From Test Statistics
If the means and standard deviations are unavailable, the effect size can also be computed from test statistics, using familiar conversion formulas. When an independent-groups t test is reported (t IG ), the independent-groups effect size estimate can be computed as follows (Glass et al., 1981) :
where n E and n C are the sample sizes from the two treatment conditions. Similarly, the repeated measures t test (t RM ) can be transformed into a repeated measures effect size (Rosenthal, 1991) ,
where n is the number of individuals or matched pairs in the experiment. For studies with an independent-groups pretestposttest design, the effect size can be computed from test statistics, as long as the designs provide equivalent estimates of the treatment effect. The estimate depends on the particular statistical test used. If a t test was computed on the difference between treatmentand control-group gain scores, then the repeated measures effect size can be estimated using
An equivalent test would be to conduct a 2 × 2 ANOVA with one between-groups factor (experimental vs. control group) and one repeated factor (pre-vs. posttest). The square root of the F test on the group by time interaction is equivalent to t gain and therefore can be substituted into Equation 29. Because the F value does not indicate the direction of the difference, the meta-analyst must also specify whether the effect size is positive or negative, depending on the pattern of means. For larger factorial designs, adjustments for the other factors should also be considered (Cortina & Nouri, 2000) . If the data were analyzed using residualized gain scores or ANCOVA, the significance test will be based on the difference between adjusted means, and therefore it will not be possible to estimate the effect size for unadjusted means from the significance test. As noted above, the difference between adjusted means will often not estimate the same treatment effect as other designs. However, in cases in which the estimates are deemed to be comparable, Glass et al. (1981) provided formulas for estimating the independent-groups effect sizes from statistical tests. If a t test on the difference in residualized gain scores (t r ) is reported,
The F test from an ANCOVA can be translated into an independent-groups effect size using
where df w is the residual within-groups degrees of freedom.
Conducting the Meta-Analysis
Meta-analysis on effect sizes from alternate designs can be performed using standard procedures, as long as (a) the effect sizes are first transformed into a common metric and (b) the appropriate sampling variance formulas are used when estimating the mean and testing for homogeneity of effect size. We present methods for the fixed-effects model (Hedges & Olkin, 1985) . The procedures can be readily generalized to random-effects models as well (Hedges & Vevea, 1998) .
The population effect size is generally estimated from a weighted mean of the effect size estimates. The rationale for weighting is to allow more precise estimates to have greater influence on the mean. If an effect size has a small sampling variance, values are likely to fall close to the population parameter. On the other hand, if the sampling variance is large, an individual estimate can differ substantially from the population effect size simply because of sampling error. By giving greater weight to more precise estimates, the resulting mean will be more accurate (i.e., will be less biased and have a smaller mean square error; Hedges & Olkin, 1985) .
Precision is largely a function of the sample size; larger samples produce more precise estimates. As a result, some have recommended weighting by sample size (Hunter & Schmidt, 1990) . When all studies are from the same design, this produces an average effect size that is very close to the optimal precisionweighted estimate (Hedges & Olkin, 1985) . However, when multiple designs are included, both the design and the sample size influence precision. For example, in a repeated measures design, each participant is treated as his or her own control, thereby reducing error variance due to individual differences. The smaller error variance results in a more precise estimate of the mean difference and, consequently, a more precise effect size estimate.
The mean effect size will be most accurate when the estimates from the individual studies are weighted by the reciprocal of the sampling variance (Hedges & Olkin, 1985) . In addition, because the design influences the formula for the sampling variance, variance weighting accounts for both sample size and study design. The variance-weighted mean effect size is
where the weights (w i ) are defined as the reciprocal of the sampling variance (1/ 2 e i ) estimated from Equation 22.
As Hedges (1982) noted, an inherent problem in meta-analysis is that it is necessary to know the population effect size in order to estimate the sampling COMBINING RESULTS ACROSS DESIGNS IN META-ANALYSIS variance, which in turn is needed to estimate the population effect size. This problem can be solved by first computing an unweighted average effect size and then using this value as the estimate of ␦ in the variance formula. These variance estimates are then used to compute the weighted mean effect size using Equation 32.
Differences in study designs must also be taken into account in tests for homogeneity of effect size. Tests for homogeneity are based on the comparison of the observed variance of the effect size ( d 2 ) to the theoretical variance due to sampling error ( e 2 ). Again, the effect of study design will be incorporated by using appropriate formulas for the sampling variance. As with the mean, variance-weighted estimates are generally used. Thus, the observed variance is
where w i ‫ס‬ 1/ e i 2 . The variance due to sampling error is estimated from the weighted average of the individual study variances, or
where k is the number of studies in the meta-analysis. Once the design effects have been taken into account in the estimates of d 2 and e 2 , standard tests for homogeneity proceed normally. Using the Hunter and Schmidt (1990) 75% rule, the effect size would be viewed as homogeneous if
Alternatively, Hedges (1982) recommended evaluating homogeneity of effect size with a significance test, which can be written as
The Q statistic is tested against a chi-square distribution with k-1 degrees of freedom. The Q statistic can also be used to test for categorical moderators of the effect size. A separate test statistic (Q j ) is computed for studies within each of the J levels of the moderator, as well as the overall statistic for all studies (Q T ). The difference between levels of the moderator can be tested using a between-groups statistic (Q B ), where
with df ‫ס‬ J − 1. Methods for simultaneous analysis of multiple moderators are described in Hedges and Olkin (1985) .
As an example, a small meta-analysis of the interpersonal skills training literature was performed. For purposes of illustration, separate meta-analyses were conducted using both the raw-score and the changescore metrics. This is not recommended in practice, where a single meta-analysis should be conducted using the metric that best addresses the research question. Table 3 presents 15 effect sizes addressing the efficacy of interpersonal skills training taken from 10 studies. The first step in this meta-analysis was to determine the design used and the relevant sample size information for each computed effect size. The first column in Table 3 contains the author of the study. The second column identifies the design used in the study. Nine of the effect sizes were based on single-group pretest-posttest designs and the remaining 6 used independent-groups posttest designs. The third and fourth columns contain sample size information for the groups (these numbers may be unequal for independent-groups posttest designs).
After identifying the design, the effect size estimates were computed. For the independent-groups posttest designs this computation was based on Equation 2 (if descriptive statistics were available) or Equation 27 (if a t test or F test was available). For effect sizes taken from single-group pretest-posttest designs, Equation 4 or Equation 28 was used, depending on whether descriptive statistics were available.
Next, Equations 11 and 12 were used to convert effect sizes from the independent-groups posttest studies into the change-score metric, and effect sizes from the single-group pretest-posttest studies into the raw-score metric, so that the results of each study were computed in each metric. Again, this step was performed only to illustrate the procedure, and only one metric should be used in practice. A small complication arises when making these transformations. Both Equation 11 and Equation 12 require informa-tion concerning the population correlation between the repeated measures. As discussed earlier, we believe that an aggregate of the correlational data across the single-group pretest-posttest designs provides the best estimate of the population correlation. Therefore, a small meta-analysis of the correlations across the single-group pretest-posttest studies was undertaken. Only the last four studies in Table 3 contained sufficient information to estimate the correlation of responses across time (.69, .72, .55, and .58) . Using Hedges and Olkin's (1985) method to meta-analyze these correlations yielded a variance-weighted average correlation of .61. Before incorporating this estimate of the correlation into our analysis, the homogeneity of the correlations was examined. The Q test yielded a nonsignificant chi-square result, 2 (3, N ‫ס‬ 245) ‫ס‬ 3.26, p > .05, indicating that the null hypothesis of homogeneity was not rejected.
The raw-score and change-score effects sizes for each study are presented in the fifth and sixth columns of Table 3 . Notice that the change-score effect sizes are uniformly larger than the raw-score effect sizes, as will generally be the case.
Once the effect sizes were computed, the next step in the meta-analysis was to estimate the sampling variance of each effect size. In addition to the values already computed, two additional pieces of information were required to use these formulas-the bias function, c, and the population effect size. The value for the bias function, c, may be computed for both effect size metrics using Equation 23.
There are many alternative ways to estimate the population effect size needed to compute the sampling variance. For most purposes, the simple average of the effect sizes in Table 3 serves as a reasonable estimate of this parameter. Across all 15 effect sizes, the av- Note. n 1 and n 2 are the sample sizes in the experimental and control group or the first and second time period, depending on the experimental design; d is the effect size estimate; c is the bias function in Equation 23 ; Var is the estimated sampling variance of the effect sizes; w is the value used to weight the effect size estimates. IG ‫ס‬ independent groups; RM ‫ס‬ repeated measures. The statistics are reported for both the raw-score and change-score effect sizes as indicated by the subscripts IG and RM, respectively.
erage raw-score effect size was 0.882 and the average change-score effect size was 0.991. The sampling variance of each effect size was estimated using the equations in Table 2 and the values just presented. As shown in Table 2 , different equations were required depending on the original study design and whether the effect size was analyzed in the original metric or transformed. Equation 32 was used to estimate the variance-weighted mean effect size. The weights were defined as the reciprocal of the sampling variance for each effect size estimate. On the basis of the values in Table 3 , the effect sizes were computed by taking the sum of the column representing the weighted effect sizes and dividing by the sum of the column representing the weights. For the change-score effect sizes this equation yielded a value of 0.77, and for the raw-score effect sizes this value was 0.69. As expected, the effect size was slightly larger in the change-score metric than in the raw-score metric. In either case, the results indicate a moderately large improvement due to training.
Next, effects sizes were tested for homogeneity. Sampling variance accounted for only a small proportion of the observed variance in effect sizes (.08 for both effect size metrics), which falls far below the Hunter and Schmidt (1990) 75% rule (Equation 35). Thus, for both metrics, there was substantial variance in the effect size estimates that could not be attributed to sampling error. Hedges' chi-square test of homogeneity resulted in similar conclusions. The chisquare homogeneity test was significant for both the raw-score metric, 2 (14, N ‫ס‬ 1161) ‫ס‬ 184.90, p < .01, and the change-score metric, 2 (14, N ‫ס‬ 1161) ‫ס‬ 183.78, p < .01. As with the 75% rule, this means that there is evidence of heterogeneity among the effect sizes, and a search for possible moderator variables is warranted.
As noted earlier, different designs may be subject to different sources of bias and therefore may not provide comparable estimates of effect size. To examine whether effect sizes could be aggregated across designs, we tested for study design as a moderator of the effect size. The moderator analysis was conducted using the fixed-effects analysis described in Hedges and Olkin (1985) for the raw-score metric. When considered separately, the effect sizes from independentgroups posttest designs were heterogeneous 2 (5, N ‫ס‬ 802) ‫ס‬ 18.72, p < .05, as were the effect sizes from the single-group pretest-posttest designs, 2 (8, N ‫ס‬ 359) ‫ס‬ 149.96, p < .05. The variance-weighted average effect size (in the raw-score metric) was 0.78 for the single-group pretest-posttest designs and 0.54 for the independent-groups posttest designs. The test of moderation indicated that the design was a significant moderator of the effect sizes,
2
(1, N ‫ס‬ 1161) ‫ס‬ 16.22, p < .05. Thus, there is evidence that even after accounting for differences in the effect sizes due to the metric, the effect sizes still differ across the designs. Substantive or bias explanations would have to be explored to identify the cause of this difference, and these effect sizes should not be combined in a single estimate of the effect of training on interpersonal skills.
Conclusion
When a meta-analyses is conducted, it is often desirable to combine results across independent-groups and repeated measures designs. When effect sizes are combined across these designs, it is critical that a number of steps be followed. Appropriate transformations must be used to ensure that all effect sizes are in a common metric. In addition, meta-analysis procedures should use design-specific sampling variance formulas to specify the precision of effect size estimates. Finally, unless the researcher can justify, based on rational analysis or empirical moderator analyses, that the alternate designs estimate the same treatment effect, the effect sizes from the two designs should not be combined. This procedure provides maximal flexibility to the meta-analyst. Researchers can choose to analyze effect sizes in either the raw-score or changescore metric, depending on which metric best reflects the pool of studies and the research question, and can readily incorporate results from studies using different designs.
A major challenge to this approach is the need to justify that effect sizes from different designs estimate the same treatment effect. Because different designs control for different types of bias, certain designs are likely to over-or underestimate the treatment effect. The researcher can justify aggregation of effect sizes across designs either rationally or empirically. Depending on the nature of the process under investigation and the specific experimental designs used, it may be possible to rule out potential sources of bias, thereby allowing estimates to be compared across designs. For example, when an intervention is examined over relatively short time periods, bias due to history or maturation can be ruled out, and time effects can be assumed to be minimal. As a result, effect sizes from independent-groups and repeated measures designs should estimate the same treatment effect. Thus, although the two designs are not comparable in general, they may be comparable in specific research domains.
The aggregation of effect sizes across designs could also be justified empirically. As a first step in conducting a meta-analysis, the researcher should test for mean differences between the effect sizes from alternate designs. If systematic differences are found, results from different designs must be analyzed separately. Alternately, the magnitude of various sources of bias could be estimated as part of the meta-analysis (Becker, 1988; Li & Begg, 1994; Shadish et al., 2000) . However, if no differences between designs are found, effect sizes could be combined. Naturally, the strongest case for aggregation can be made when both rational and empirical justification can be provided.
A limitation of the repeated measures effect size is that it compares only two time periods. In many research areas in which the repeated measures effect size would be of greatest interest (e.g., practice or learning effects), it is often beneficial to observe the trajectory of growth curves across multiple observations (Keppel, 1982) . The use of a single pretestposttest comparison might miss important information about the shape of growth trajectories. However, it should be noted that this problem is inherent in any meta-analysis using standardized mean differences, not just the methods proposed here. Becker (1988) suggested that this could be addressed by computing multiple comparisons within each study and then using a meta-analysis procedure that models both within-and between-studies effects.
Combining effect sizes estimated from studies using different research designs is a challenging and often time-consuming process. In this presentation, we detailed the methods required to appropriately combine effect sizes from repeated measures and independent-groups designs and highlighted the inferential hazards that may be encountered when doing so. However, it should be emphasized that the difficulties highlighted above (e.g., differences in metric and differential susceptibility to bias) are not unique to combining effects sizes across dependent-and independent-groups designs. In fact, virtually all of these issues should be considered when combining effect sizes across different independent-groups designs (cf. Morris & DeShon, 1997) . We recommend that when a meta-analysis is conducted, it should be common practice to record differences in design and to examine experimental design as a moderator of the effect sizes.
